Tom Price Intervened on a Rule That Would Hurt Drug Profits, the Same Day He Acquired Drug Stock

(Before It's News)

By Robert Faturechi / ProPublica

While in Congress, HHS Secretary Tom Price acted to help kill a rule that would hurt drug company profits shortly after his broker bought him up to $90,000 worth of pharmaceutical stock.

Related Entries

• April 2, 2017 As Seas Around Mar-a-Lago Rise, Trump’s Budget Cuts Could Thwart a Local Climate Action Plan
• March 28, 2017 Democratic Senators Ask Jeff Sessions to Explain Preet Bharara Firing

• How to blow up a minivan with dynamite, diesel fuel and a tank (VIDEO)
• Doug Stanhope: F**k the Jews
• the green goo doomsday scenario
• North Korea Fires Ballistic Missile Into East Sea As US Warns “Clock Has Run Out”
• Kp Message 4-5-17… “Not involved at All”
• Benghazi Survivor: Nunes Can Do The Job, And Schiff Should Help Or Shut Up

• Theresa May – A Role Model For Women In Saudi Arabia
• U.S. Withdraws Funding for U.N. Population Fund (Coercive abortion or involuntary sterilization)
• Creating Miracles in Your Life with the Law of Attraction – Stuart Wilde
• Without the Oceans, You Wouldn’t Exist